LNAI
LNAI
NASDAQ · Biotechnology

Lunai Bioworks Inc

$0.16
-0.07 (-30.20%)
Financial Highlights (FY 2026)
Revenue
78.0K
Net Income
-5,336,521
Gross Margin
100.0%
Profit Margin
-6,852.2%
Rev Growth
—
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 100.0% 67.4% 67.4% 67.4%
Operating Margin -7,875.4% -19.9% -16.9% -16.7%
Profit Margin -6,852.2% -18.4% -19.0% -14.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 78.0K 6.85M 7.13M 6.14M
Gross Profit 78.0K 4.62M 4.80M 4.14M
Operating Income -6,145,489 -1,362,333 -1,203,383 -1,026,501
Net Income -5,336,521 -1,263,411 -1,351,255 -906,681
Gross Margin 100.0% 67.4% 67.4% 67.4%
Operating Margin -7,875.4% -19.9% -16.9% -16.7%
Profit Margin -6,852.2% -18.4% -19.0% -14.8%
Rev Growth — +20.2% +21.4% +12.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 7.6K 2.95M 3.44M 3.00M
Total Equity 407.3K 8.99M 9.30M 10.51M
D/E Ratio 0.02 0.33 0.37 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,993,013 -2,085,898 -2,131,542 -1,625,986
Free Cash Flow — -871,023 -1,277,993 -924,733